Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls
Identifieur interne : 001D43 ( Istex/Corpus ); précédent : 001D42; suivant : 001D44Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls
Auteurs : Lorraine O. Ramig ; Shimon Sapir ; Cynthia Fox ; Stefanie CountrymanSource :
- Movement Disorders [ 0885-3185 ] ; 2001-01.
English descriptors
- KwdEn :
Abstract
This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.
Url:
DOI: 10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H
Links to Exploration step
ISTEX:531A9FD63A9D9C568514238B7209E95B66D73BD4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title><author><name sortKey="Ramig, Lorraine O" sort="Ramig, Lorraine O" uniqKey="Ramig L" first="Lorraine O." last="Ramig">Lorraine O. Ramig</name><affiliation><mods:affiliation>Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado</mods:affiliation></affiliation><affiliation><mods:affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</mods:affiliation></affiliation></author><author><name sortKey="Sapir, Shimon" sort="Sapir, Shimon" uniqKey="Sapir S" first="Shimon" last="Sapir">Shimon Sapir</name><affiliation><mods:affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</mods:affiliation></affiliation></author><author><name sortKey="Fox, Cynthia" sort="Fox, Cynthia" uniqKey="Fox C" first="Cynthia" last="Fox">Cynthia Fox</name><affiliation><mods:affiliation>National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona</mods:affiliation></affiliation></author><author><name sortKey="Countryman, Stefanie" sort="Countryman, Stefanie" uniqKey="Countryman S" first="Stefanie" last="Countryman">Stefanie Countryman</name><affiliation><mods:affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:531A9FD63A9D9C568514238B7209E95B66D73BD4</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H</idno><idno type="url">https://api.istex.fr/document/531A9FD63A9D9C568514238B7209E95B66D73BD4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001D43</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title><author><name sortKey="Ramig, Lorraine O" sort="Ramig, Lorraine O" uniqKey="Ramig L" first="Lorraine O." last="Ramig">Lorraine O. Ramig</name><affiliation><mods:affiliation>Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado</mods:affiliation></affiliation><affiliation><mods:affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</mods:affiliation></affiliation></author><author><name sortKey="Sapir, Shimon" sort="Sapir, Shimon" uniqKey="Sapir S" first="Shimon" last="Sapir">Shimon Sapir</name><affiliation><mods:affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</mods:affiliation></affiliation></author><author><name sortKey="Fox, Cynthia" sort="Fox, Cynthia" uniqKey="Fox C" first="Cynthia" last="Fox">Cynthia Fox</name><affiliation><mods:affiliation>National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona</mods:affiliation></affiliation></author><author><name sortKey="Countryman, Stefanie" sort="Countryman, Stefanie" uniqKey="Countryman S" first="Stefanie" last="Countryman">Stefanie Countryman</name><affiliation><mods:affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-01">2001-01</date><biblScope unit="vol">16</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="79">79</biblScope><biblScope unit="page" to="83">83</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">531A9FD63A9D9C568514238B7209E95B66D73BD4</idno><idno type="DOI">10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H</idno><idno type="ArticleID">MDS1013</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>LSVT®</term><term>Parkinson's disease</term><term>dysarthria</term><term>speech therapy</term><term>vocal loudness</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Lorraine O. Ramig PhD</name><affiliations><json:string>Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado</json:string><json:string>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</json:string></affiliations></json:item><json:item><name>Shimon Sapir PhD</name><affiliations><json:string>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</json:string></affiliations></json:item><json:item><name>Cynthia Fox MA, CCC‐SLP</name><affiliations><json:string>National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona</json:string></affiliations></json:item><json:item><name>Stefanie Countryman MA, CCC‐SLP</name><affiliations><json:string>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>LSVT®</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>speech therapy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>vocal loudness</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dysarthria</value></json:item></subject><language><json:string>eng</json:string></language><abstract>This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.</abstract><qualityIndicators><score>5.549</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1445</abstractCharCount><pdfWordCount>2933</pdfWordCount><pdfCharCount>19397</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>218</abstractWordCount></qualityIndicators><title>Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title><genre><json:string>Serial article</json:string></genre><host><volume>16</volume><pages><total>5</total><last>83</last><first>79</first></pages><issn><json:string>0885-3185</json:string></issn><issue>1</issue><subject><json:item><value>Research Article</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2001</publicationDate><copyrightDate>2001</copyrightDate><doi><json:string>10.1002/1531-8257(200101)16:1>79::AID-MDS1013>3.0.CO;2-H</json:string></doi><id>531A9FD63A9D9C568514238B7209E95B66D73BD4</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/531A9FD63A9D9C568514238B7209E95B66D73BD4/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/531A9FD63A9D9C568514238B7209E95B66D73BD4/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/531A9FD63A9D9C568514238B7209E95B66D73BD4/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><availability><p>John Wiley & Sons, Inc.</p></availability><date>2001</date></publicationStmt><notesStmt><note>NIH‐NIDCD - No. R01 DC‐01150;</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title><author><persName><forename type="first">Lorraine O.</forename><surname>Ramig</surname><roleName type="degree">PhD</roleName></persName><note type="correspondence"><p>Correspondence: Wilbur James Gould Voice Research Center, Denver Center for the Performing Arts, 1245 Champa Street, Denver, Colorado 80204</p></note><affiliation>Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado</affiliation><affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</affiliation></author><author><persName><forename type="first">Shimon</forename><surname>Sapir</surname><roleName type="degree">PhD</roleName></persName><affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</affiliation></author><author><persName><forename type="first">Cynthia</forename><surname>Fox</surname><roleName type="degree">MA, CCC‐SLP</roleName></persName><affiliation>National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona</affiliation></author><author><persName><forename type="first">Stefanie</forename><surname>Countryman</surname><roleName type="degree">MA, CCC‐SLP</roleName></persName><affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-01"></date><biblScope unit="vol">16</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="79">79</biblScope><biblScope unit="page" to="83">83</biblScope></imprint></monogr><idno type="istex">531A9FD63A9D9C568514238B7209E95B66D73BD4</idno><idno type="DOI">10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H</idno><idno type="ArticleID">MDS1013</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2001</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>LSVT®</term></item><item><term>Parkinson's disease</term></item><item><term>speech therapy</term></item><item><term>vocal loudness</term></item><item><term>dysarthria</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Research Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2000-01-27">Received</change><change when="2000-07-01">Registration</change><change when="2001-01">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/531A9FD63A9D9C568514238B7209E95B66D73BD4/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Inc.</publisherName><publisherLoc>New York</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="10"><doi origin="wiley" registered="yes">10.1002/1531-8257(200101)16:1<>1.0.CO;2-F</doi><numberingGroup><numbering type="journalVolume" number="16">16</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="2001-01">January 2001</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="11" status="forIssue"><doi origin="wiley" registered="yes">10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H</doi><idGroup><id type="unit" value="MDS1013"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Research Article</title><title type="tocHeading1">Research Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 2001 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2000-01-27"></event><event type="manuscriptRevised" date="2000-06-27"></event><event type="manuscriptAccepted" date="2000-07-01"></event><event type="firstOnline" date="2001-01-23"></event><event type="publishedOnlineFinalForm" date="2001-01-23"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.5 mode:FullText source:FullText result:FullText" date="2010-04-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">79</numbering><numbering type="pageLast">83</numbering></numberingGroup><correspondenceTo>Wilbur James Gould Voice Research Center, Denver Center for the Performing Arts, 1245 Champa Street, Denver, Colorado 80204</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS1013.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="27"></count><count type="wordTotal" number="2792"></count></countGroup><titleGroup><title type="main" xml:lang="en">Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title><title type="short" xml:lang="en">Changes in Vocal Loudness</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2" corresponding="yes"><personName><givenNames>Lorraine O.</givenNames><familyName>Ramig</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Shimon</givenNames><familyName>Sapir</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Cynthia</givenNames><familyName>Fox</familyName><degrees>MA, CCC‐SLP</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Stefanie</givenNames><familyName>Countryman</familyName><degrees>MA, CCC‐SLP</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">LSVT®</keyword><keyword xml:id="kwd2">Parkinson's disease</keyword><keyword xml:id="kwd3">speech therapy</keyword><keyword xml:id="kwd4">vocal loudness</keyword><keyword xml:id="kwd5">dysarthria</keyword></keywordGroup><fundingInfo><fundingAgency>NIH‐NIDCD</fundingAgency><fundingNumber>R01 DC‐01150</fundingNumber></fundingInfo><supportingInformation><p> This was supported by NH‐NDCD R01 DC‐01150 and presented at the International Conference on Movement Disorders, New York, October, 1998 </p></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Changes in Vocal Loudness</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls</title></titleInfo><name type="personal"><namePart type="given">Lorraine O.</namePart><namePart type="family">Ramig</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado</affiliation><affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</affiliation><description>Correspondence: Wilbur James Gould Voice Research Center, Denver Center for the Performing Arts, 1245 Champa Street, Denver, Colorado 80204</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Shimon</namePart><namePart type="family">Sapir</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Cynthia</namePart><namePart type="family">Fox</namePart><namePart type="termsOfAddress">MA, CCC‐SLP</namePart><affiliation>National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Stefanie</namePart><namePart type="family">Countryman</namePart><namePart type="termsOfAddress">MA, CCC‐SLP</namePart><affiliation>Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>John Wiley & Sons, Inc.</publisher><place><placeTerm type="text">New York</placeTerm></place><dateIssued encoding="w3cdtf">2001-01</dateIssued><dateCaptured encoding="w3cdtf">2000-01-27</dateCaptured><dateValid encoding="w3cdtf">2000-07-01</dateValid><copyrightDate encoding="w3cdtf">2001</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">2</extent><extent unit="references">27</extent><extent unit="words">2792</extent></physicalDescription><abstract lang="en">This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.</abstract><note type="funding">NIH‐NIDCD - No. R01 DC‐01150; </note><subject lang="en"><genre>Keywords</genre><topic>LSVT®</topic><topic>Parkinson's disease</topic><topic>speech therapy</topic><topic>vocal loudness</topic><topic>dysarthria</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><note type="content"> This was supported by NH‐NDCD R01 DC‐01150 and presented at the International Conference on Movement Disorders, New York, October, 1998</note><subject><genre>article category</genre><topic>Research Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>79</start><end>83</end><total>5</total></extent></part></relatedItem><identifier type="istex">531A9FD63A9D9C568514238B7209E95B66D73BD4</identifier><identifier type="DOI">10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H</identifier><identifier type="ArticleID">MDS1013</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2001 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>John Wiley & Sons, Inc.</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D43 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001D43 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:531A9FD63A9D9C568514238B7209E95B66D73BD4
|texte= Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls
}}
| This area was generated with Dilib version V0.6.23. |  |